What question did this study set out to answer?

To describe a case of metanephrine-secreting adrenocortical carcinoma in a dog, highlighting its clinical and biochemical features.

Metanephrine-secreting adrenocortical carcinoma in a dog with clinical and biochemical features suggestive of pheochromocytoma

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial investigates metanephrine-secreting adrenocortical carcinoma in a dog, suggesting important clinical insights.

To describe a case of metanephrine-secreting adrenocortical carcinoma in a dog, highlighting its clinical and biochemical features.
Patient presented with an adrenal mass and systemic hypertension.
Computed tomography (CT) and histopathology were utilized for diagnosis.
Laparoscopic adrenalectomy performed after phenoxybenzamine therapy.
The dog's blood pressure normalized post-surgery, maintaining normotension over 11 months.
Histopathology confirmed adrenal cortical carcinoma with tumor emboli.
Immunohistochemistry supported the diagnosis with noted differentiation characteristics.

Kim et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark